Results 221 to 230 of about 224,404 (241)

Human medicines European public assessment report (EPAR): Bonviva, ibandronic acid, Osteoporosis, Postmenopausal, Date of authorisation: 23/02/2004, Revision: 25, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

The Pmpo Syndrome (Postmenopausal Palpable Ovary Syndrome)

Ca-A Cancer Journal for Clinicians, 1972
Edward A Graber, Hugh R K Barber, H R K Barber   +2 more
exaly  

Human medicines European public assessment report (EPAR): Fosavance, alendronic acid / colecalciferol, Osteoporosis, Postmenopausal, Date of authorisation: 24/08/2005, Revision: 22, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Aging and Osteoporosis in Breast and Prostate Cancer

Ca-A Cancer Journal for Clinicians, 2011
Arti Hurria, Ari VanderWalde
exaly  

Human medicines European public assessment report (EPAR): Prolia, denosumab, Bone Resorption,Osteoporosis, Postmenopausal, Date of authorisation: 26/05/2010, Revision: 21, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Treatment of Postmenopausal Osteoporosis

New England Journal of Medicine, 1998
Richard Eastell
exaly   +2 more sources

Ten Years' Experience With Alendronate for Osteoporosis in Postmenopausal Women

New England Journal of Medicine, 2004
Arthur Santora, Henry Bone, Jean-Pierre Devogelaer   +2 more
exaly  

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of authorisation: 15/04/2005, Revision: 26, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Postmenopausal Osteoporosis

New England Journal of Medicine, 2016
Dennis M Black, Clifford J Rosen
exaly  

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of authorisation: 15/04/2005, Revision: 25, Status: Authorised

Case Medical Research, 2018
openaire   +1 more source